Page last updated: 2024-10-25

clofibrate and Carcinoma 256, Walker

clofibrate has been researched along with Carcinoma 256, Walker in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Clofibrate was also found to potentiate the antitumor effect of hydrazine sulfate, cytotoxic drugs and the combination of hydrazine sulfate + cytotoxic drug."1.26Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma. ( Gold, J, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gold, J1

Other Studies

1 other study available for clofibrate and Carcinoma 256, Walker

ArticleYear
Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Cancer biochemistry biophysics, 1978, Volume: 3, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Clofibrate; Dose-Response Relationship, Drug;

1978